SG54339A1 - Novel crystal form of anhydrous 7-(1alpha,salpha, 6alpha,]-6-amino-3-azabicyclo [3.1.0]hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl) (pls refer to file for full detail) - Google Patents

Novel crystal form of anhydrous 7-(1alpha,salpha, 6alpha,]-6-amino-3-azabicyclo [3.1.0]hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl) (pls refer to file for full detail)

Info

Publication number
SG54339A1
SG54339A1 SG1996009972A SG1996009972A SG54339A1 SG 54339 A1 SG54339 A1 SG 54339A1 SG 1996009972 A SG1996009972 A SG 1996009972A SG 1996009972 A SG1996009972 A SG 1996009972A SG 54339 A1 SG54339 A1 SG 54339A1
Authority
SG
Singapore
Prior art keywords
salpha
6alpha
1alpha
pls
azabicyclo
Prior art date
Application number
SG1996009972A
Other languages
English (en)
Inventor
Lynne A Handanyan
Phillip J Johnson
Robert L Hendrickson
Thomas A Morris
Timothy Norris
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SG54339A1 publication Critical patent/SG54339A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SG1996009972A 1995-06-06 1996-06-05 Novel crystal form of anhydrous 7-(1alpha,salpha, 6alpha,]-6-amino-3-azabicyclo [3.1.0]hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl) (pls refer to file for full detail) SG54339A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/007211 WO1996039406A1 (en) 1995-06-06 1995-06-06 NOVEL CRYSTAL FORM OF ANHYDROUS 7-([1α, 5α, 6α]-6-AMINO-3-AZABICYCLO[3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT

Publications (1)

Publication Number Publication Date
SG54339A1 true SG54339A1 (en) 1998-11-16

Family

ID=39431076

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996009972A SG54339A1 (en) 1995-06-06 1996-06-05 Novel crystal form of anhydrous 7-(1alpha,salpha, 6alpha,]-6-amino-3-azabicyclo [3.1.0]hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl) (pls refer to file for full detail)

Country Status (38)

Country Link
US (1) US5763454A (cs)
EP (1) EP0789697B1 (cs)
JP (1) JP3145715B2 (cs)
KR (1) KR100191989B1 (cs)
CN (1) CN1055474C (cs)
AR (1) AR002753A1 (cs)
AU (1) AU703634B2 (cs)
BG (1) BG62443B1 (cs)
BR (1) BR9602630A (cs)
CA (1) CA2223404C (cs)
CZ (1) CZ285878B6 (cs)
DE (1) DE69503066T2 (cs)
DK (1) DK0789697T3 (cs)
DZ (1) DZ2046A1 (cs)
ES (1) ES2117426T3 (cs)
FI (1) FI974441A7 (cs)
HR (1) HRP960267B1 (cs)
HU (1) HUP9601540A3 (cs)
IL (1) IL118488A (cs)
IS (1) IS4351A (cs)
LV (1) LV11619B (cs)
MA (1) MA23892A1 (cs)
NO (1) NO305599B1 (cs)
NZ (1) NZ286735A (cs)
OA (1) OA10293A (cs)
PE (1) PE38097A1 (cs)
PL (1) PL314604A1 (cs)
RU (1) RU2125571C1 (cs)
SG (1) SG54339A1 (cs)
SI (1) SI9600185A (cs)
SK (1) SK280535B6 (cs)
TN (1) TNSN96084A1 (cs)
TW (2) TW403751B (cs)
UA (1) UA44718C2 (cs)
UY (1) UY25459A1 (cs)
WO (1) WO1996039406A1 (cs)
YU (1) YU34596A (cs)
ZA (1) ZA964647B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
MA24500A1 (fr) 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
DE19800214A1 (de) 1998-01-06 1999-07-15 Knoll Ag Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür
US7019142B2 (en) * 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
GB9818258D0 (en) * 1998-08-21 1998-10-14 Pfizer Ltd Antifungal compositions
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
GB9820405D0 (en) * 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
ES2164520B1 (es) * 1999-03-16 2003-04-01 Medichem Sa "procedimiento de obtencion del polimorfo a del mesilato de doxazosina"
US6239141B1 (en) 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
US6531603B1 (en) 2001-06-29 2003-03-11 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6657061B2 (en) 2001-06-29 2003-12-02 Grayson Walker Stowell Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6388080B1 (en) 2001-06-29 2002-05-14 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6596871B2 (en) 2001-06-29 2003-07-22 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6660864B2 (en) 2001-06-29 2003-12-09 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6573382B2 (en) 2001-06-29 2003-06-03 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
CN102512364A (zh) * 2011-12-30 2012-06-27 天津市嵩锐医药科技有限公司 一种供注射用的甲磺酸阿拉曲伐沙星药物组合物
TWI608970B (zh) * 2013-01-11 2017-12-21 參天製藥股份有限公司 內塞和具備該內塞的液體收容容器、以及注口的前端構造和具備該構造的液體收容容器

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL166381B1 (pl) * 1989-08-16 1995-05-31 Pfizer Sposób wytwarzania nowych podstawionych kwasów 7-azabicyklochinolonokarboksylowych PL PL PL PL
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
CZ286896B6 (en) * 1994-01-18 2000-07-12 Pfizer Process for preparing pharmaceutically acceptable salts of naphthyridone carboxylic acid and intermediates for this preparation
GB2289674A (en) * 1994-05-23 1995-11-29 Pfizer Antibacterial naphthyridine

Also Published As

Publication number Publication date
CZ285878B6 (cs) 1999-11-17
HUP9601540A3 (en) 1997-05-28
YU34596A (sh) 1999-03-04
HRP960267B1 (en) 2000-06-30
EP0789697A1 (en) 1997-08-20
IL118488A (en) 1999-01-26
DE69503066D1 (de) 1998-07-23
ZA964647B (en) 1997-10-22
NO962321D0 (no) 1996-06-05
NZ286735A (en) 1998-01-26
IL118488A0 (en) 1996-09-12
CA2223404A1 (en) 1996-12-12
KR100191989B1 (ko) 1999-06-15
PE38097A1 (es) 1997-10-10
HRP960267A2 (en) 1997-08-31
RU2125571C1 (ru) 1999-01-27
AU703634B2 (en) 1999-03-25
BR9602630A (pt) 1998-09-08
UA44718C2 (uk) 2002-03-15
UY25459A1 (es) 1999-11-17
JPH10506650A (ja) 1998-06-30
CZ162596A3 (cs) 1998-09-16
AU5474996A (en) 1996-12-19
MA23892A1 (fr) 1996-12-31
DZ2046A1 (fr) 2002-10-22
HU9601540D0 (en) 1996-07-29
JP3145715B2 (ja) 2001-03-12
DE69503066T2 (de) 1998-10-15
DK0789697T3 (da) 1998-10-19
SK280535B6 (sk) 2000-03-13
SK71996A3 (en) 1997-03-05
EP0789697B1 (en) 1998-06-17
NO305599B1 (no) 1999-06-28
FI974441A0 (fi) 1997-12-05
CN1148596A (zh) 1997-04-30
MX9709873A (es) 1998-03-31
LV11619A (lv) 1996-12-20
TW580389B (en) 2004-03-21
KR970001352A (ko) 1997-01-24
FI974441L (fi) 1997-12-05
HUP9601540A2 (en) 1997-02-28
US5763454A (en) 1998-06-09
LV11619B (en) 1997-04-20
BG62443B1 (bg) 1999-11-30
IS4351A (is) 1996-12-07
TNSN96084A1 (fr) 2005-03-15
CA2223404C (en) 2001-01-16
CN1055474C (zh) 2000-08-16
TW403751B (en) 2000-09-01
PL314604A1 (en) 1996-12-09
AR002753A1 (es) 1998-04-29
OA10293A (en) 1997-09-19
ES2117426T3 (es) 1998-08-01
FI974441A7 (fi) 1997-12-05
SI9600185A (en) 1997-04-30
BG100639A (bg) 1997-02-28
NO962321L (no) 1996-12-09
WO1996039406A1 (en) 1996-12-12

Similar Documents

Publication Publication Date Title
SG54339A1 (en) Novel crystal form of anhydrous 7-(1alpha,salpha, 6alpha,]-6-amino-3-azabicyclo [3.1.0]hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl) (pls refer to file for full detail)
YU59600A (sh) Supstituisane indolalkanoidske kiseline
AU4972596A (en) Improved tibial osteotomy system
GR3036315T3 (en) Indolinone compounds for the treatment of disease
AU1021097A (en) Improved process for the synthesis of oligomeric compounds
HUP9801692A3 (en) Benzimidazole compounds, pharmaceutical compositions containing them and their use for producing pharmaceutical compositions
EP0637630A3 (en) Method for the biological synthesis of peptides
MY117032A (en) A novel compound form.
HUP9802264A3 (en) System for measuring blood oxygen levels
AU7249198A (en) Substantially pure zonulin, a physiological modulator of mammalian tight junctions
HRP970130A2 (en) Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
IL117459A (en) Dna encoding human papillomavirus type 18
AU8534291A (en) Renal-selective angiotensin ii antagonists for treatment of hypertension
AU3217595A (en) Stabilized compositions containing hemoglobin
NO975581D0 (no) Fremgangsmåte for å redusere bentap
AU2634597A (en) Compounds with growth hormone releasing properties
AU5368296A (en) Nitrosylated blood substitutes
AU4208897A (en) Oligocistronic expression system for the production of heteromeric proteins
AU2205099A (en) Chimeric proteins for the treatment of diabetes
EP0946411A4 (en) METHOD FOR PRODUCING NITRIDE CRYSTALS OF THE 3 MAIN GROUP
AU4282599A (en) Method to prepare c-terminal modified peptides
AU6845294A (en) Improvements to beds for clinical use
NO975560D0 (no) Fremgangsmåte for å redusere bentap
AU3452700A (en) Antibodies to placental protein 13
AU4811697A (en) Improved process for the synthesis of beta-ketonitriles